Does the pharmacological class effect between the different luteinizing hormone releasing hormone analogues used in the treatment of prostate cancer have to be assumed?
S. Vilar-González, X. Maldonado-Pijuan, I. Andrés-GarcíaVolume:
34
Year:
2010
DOI:
10.1016/s2173-5786(10)70190-6
File:
PDF, 230 KB
2010